1EDITORIAL BOARD1699-16992MANUSCRIPT PREPARATION1700-17003Methods for the analysis of neuronal plasticity and brain connectivity during neurological recoveryEduardo H.Sanchez-Mendoza, Tayana Silva de Carvalho, Dirk M.Hermann1701-17034Applicability of tooth derived stem cells in neural regenerationLudovica Parisi, Edoardo Manfredi1704-17075The status of Nrf2-based therapeutics：current perspectives and future prospectsIrina G Gazaryan, Bobby Thomas1708-17116Six psychotropics for pre-symptomatic & early Alzheimer’s (MCI), Parkinson’s, and Huntington’s disease modiifcationEdward C. Lauterbach1712-17267Neuroinlfammation, neurodegeneration and regeneration in multiple sclerosis：intercorrelated manifestations of the immune responseTatiana Koudriavtseva, Caterina Mainero1727-17308Targeting neuronal nitric oxide synthase as a valuable strategy for the therapy of neurological disordersCristina Maccallini, Rosa Amoroso1731-17349The Epigenome as a therapeutic target for Parkinson’s diseaseShane V. Hegarty, Aideen M. Sullivan, Gerard W. O’Keeffe1735-173810Astroglial heterogeneity：merely a neurobiological question? Or an opportunity for neuroprotection and regeneration atfer brain injury?1739-174111Anti-inlfammatory properties of the glial scar1742-174312Neuroprotection by salubrinal treatment in global cerebral ischemia1744-174513Reversing multiple age-related pathologies by controlling the senescence-associated secretory phenotype of stem cells1746-174714Adult neurogenesis and in vivo reprogramming：combining strategies for endogenous brain repair1748-174915Pretreatment of caffeine leads to partial neuroprotection in MPTP model of Parkinson’s disease1750-175116Molecular mechanisms of NMDA receptor-mediated excitotoxicity:implications for neuroprotective therapeutics for stroke1752-175317Targeting lysophospholipid signaling as a therapeutic approach towards improved peripheral nerve regeneration1754-175518HSP70 cleavage-induced photoreceptor cell death caused by N-methyl-N-nitrosourea1758-175919Chaperoning glucocerebrosidase：a therapeutic strategy for both Gaucher disease and Parkinsonism1760-176120Spinal cord injury：potential neuroprotective therapy based on neural-derived peptides1762-1763 